Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,377 | 91,395 | 341,768 | 287,730 | 120,268 |
| Marketable Securities | 101,617 | 140,579 | 149,863 | 318,680 | 530,047 |
| Receivables | 19,116 | N/A | N/A | N/A | N/A |
| Inventories | 17,728 | N/A | N/A | N/A | N/A |
| Other current assets | 30,000 | 0 | 0 | 7,432 | 4,144 |
| TOTAL | $379,354 | $241,724 | $502,320 | $613,842 | $654,459 |
| Non-Current Assets | |||||
| PPE Net | 266,053 | 238,077 | 154,913 | 70,802 | 42,111 |
| Investments And Advances | 48,928 | 165,106 | 13,362 | 0 | 0 |
| Intangibles | 455,049 | 31,309 | 32,311 | 0 | 0 |
| Other Non-Current Assets | 13,770 | 37,516 | 39,124 | 33,174 | 33,328 |
| TOTAL | $783,800 | $472,008 | $239,710 | $103,976 | $75,439 |
| Total Assets | $1,163,154 | $713,732 | $742,030 | $717,818 | $729,898 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 544 | 502 | 466 | 432 |
| Accounts payable and accrued liabilities | 2,728 | 4,921 | 3,644 | 1,628 | 1,249 |
| Accrued Expenses | 19,626 | 6,977 | 10,903 | 7,918 | 7,659 |
| Other current liabilities | 676 | N/A | N/A | N/A | N/A |
| TOTAL | $72,052 | $43,454 | $35,072 | $14,626 | $12,563 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 7,770 | 8,523 | 8,426 | 8,892 |
| Deferred Revenues | 11,290 | 17,389 | 161 | 38 | 100 |
| Other Non-Current Liabilities | 507,294 | 249,998 | 250,104 | 150,000 | 150,000 |
| TOTAL | $565,037 | $257,768 | $258,627 | $158,426 | $158,892 |
| Total Liabilities | $637,089 | $301,222 | $293,699 | $173,052 | $171,455 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,182 | 96,070 | 93,936 | 89,181 | 88,649 |
| Common Shares | 1,121 | 959 | 939 | 892 | 885 |
| Retained earnings | -440,109 | -273,532 | -220,291 | -90,477 | -75,923 |
| Other shareholders' equity | -4,065 | -1,219 | 890 | 6,059 | 9,387 |
| TOTAL | $526,065 | $412,510 | $448,331 | $544,766 | $558,443 |
| Total Liabilities And Equity | $1,163,154 | $713,732 | $742,030 | $717,818 | $729,898 |